Dianthus Therapeutics, Inc. (DNTH)
90.83
+3.35
(+3.83%)
USD |
NASDAQ |
Apr 09, 15:19
Dianthus Therapeutics Shareholders Equity (Quarterly) : 493.40M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Sarepta Therapeutics, Inc. | 1.141B |
| Daré Bioscience, Inc. | 2.843M |
| Relmada Therapeutics, Inc. | 86.51M |
| Viridian Therapeutics, Inc. | 722.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 531.40M |
| Total Liabilities (Quarterly) | 38.00M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | -0.01% |